Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
Oct 5, 2026, 13:01

Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives

Nawsherwan Mohammad, Consultant Hematopathologist at Nanakaly Hospital, shared a post on LinkedIn about a recent article by Stephen MacDonald et al., published in BJHaem, adding:

“Suspected TTP is a medical emergency – don’t wait for ADAMTS13 to treat when clinical suspicion is high.

A practical summary of the 2026 BSH laboratory guidance on thrombotic thrombocytopenic purpura:

  • Think TTP when thrombocytopenia plus microangiopathic haemolytic anaemia occur together.
  • Look for marked thrombocytopenia, schistocytes, reticulocytosis, elevated LDH, low haptoglobin, and usually normal coagulation.
  • Send a pre-treatment ADAMTS13 sample – ideally 3.2% sodium citrate, not EDTA – but never delay treatment.
  • ADAMTS13 activity less than 10 IU/dL strongly supports TTP.
  • 10–20 IU/dL is a grey zone, not an automatic negative.
  • If less than 10 IU/dL, test anti-ADAMTS13 antibodies within 72 hours.
  • Antibody-negative does not prove congenital TTP – genetic testing is required.
  • For monitoring, use the same assay platform whenever possible.

Key message: rapid recognition, early sampling, and urgent treatment save lives.”

Title: Diagnosis and monitoring of thrombotic thrombocytopenic purpura: Guidance for laboratories from the British Society for Haematology

Authors: Stephen MacDonald, Thomas Pitchford, Deepak Singh, Rebekah Fretwell, P. Vince Jenkins, Caroline Lawrence, Richard Gooding, Sean Platton

Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives

Stay updated with Hemostasis Today.